Prostate Cancer

Top Story

Fewer newly diagnosed patients with cancer lack insurance after ACA

Fewer newly diagnosed patients with cancer lack insurance after ACA
October 19, 2017

Uninsurance rates among patients newly diagnosed with cancer dropped one-third during the Affordable Care Act’s first year of implementation, according to study results.

Since implementation of the ACA in 2014, the number of uninsured individuals has reached a historical low.

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

October 17, 2017
Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized…

NIH collaboration aims to identify, validate immunotherapy biomarkers

October 13, 2017
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration. The $215 million effort is part of the national cancer…
In the Journals PlusPerspective

Genetic variant predicts clinical response to prostate cancer therapy

October 12, 2017
The presence of HSD3B1 variant predicted clinical outcomes to certain therapies among men treated for localized and metastatic castration-resistant prostate cancers…
More Headlines »
CME

Expert Update: What's New in Essential Thrombocythemia

This activity is supported by an educational grant from Incyte Corporation.

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms…
More »
Video

Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis

September 25, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Advertisement
Advertisement